ULTIBRO BREEZHALER

Identification of Ultibro Breezhaler

No description

Google image searchProduct monograph

Active ingredients

glycopyrronium (glycopyrronium bromide), 50 MCG

indacaterol (indacaterol maleate), 110 MCG

DIN: 02418282

Dosage form(s): CAPSULE

Route(s) of administration: INHALATION

Description: CAPSULE TO BE USED ONLY WITH ULTIBRO BREEZHALER DEVICE - ORAL INHALATION

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 05-MAR-2014

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03A — ADRENERGICS, INHALANTS (ATC, ATC/DDD)
• R03AL — Adrenergics in combination with anticholinergics (ATC, ATC/DDD)
• R03AL04 — INDACATEROL AND GLYCOPYRRONIUM BROMIDE (ATC/DDD)

Reference brand drug: Ultibro

External Links for Ultibro Breezhaler

Search on Google

• Ultibro Breezhaler side effects
• Ultibro Breezhaler dosage
• glycopyrronium side effects
• glycopyrronium dosage
• indacaterol side effects
• indacaterol dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find ultibro breezhaler photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.